S
Shervin Shokouhi
Researcher at Shahid Beheshti University of Medical Sciences and Health Services
Publications - 69
Citations - 1706
Shervin Shokouhi is an academic researcher from Shahid Beheshti University of Medical Sciences and Health Services. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 11, co-authored 60 publications receiving 1141 citations.
Papers
More filters
Journal ArticleDOI
Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19).
Mohammad M. Sajadi,Mohammad M. Sajadi,Parham Habibzadeh,Augustin Vintzileos,Shervin Shokouhi,Fernando Miralles-Wilhelm,Fernando Miralles-Wilhelm,Anthony Amoroso,Anthony Amoroso +8 more
TL;DR: In this cohort study of 50 cities with and without coronavirus disease 2019, areas with substantial community transmission of COVID-19 had distribution roughly along the 30° N to 50° N latitude corridor with consistently similar weather patterns, consisting of mean temperatures of 5 to 11 °C combined with low specific and absolute humidity.
Journal ArticleDOI
Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19
Mohammad M. Sajadi,Parham Habibzadeh,Augustin Vintzileos,Shervin Shokouhi,Fernando Miralles-Wilhelm,Fernando Miralles-Wilhelm,Anthony Amoroso +6 more
TL;DR: Using weather modeling, it may be possible to predict the regions most likely to be at higher risk of significant community spread of COVID-19 in the upcoming weeks, allowing for concentration of public health efforts on surveillance and containment.
Journal ArticleDOI
Aminoquinolines Against Coronavirus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine
TL;DR: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record.
Journal ArticleDOI
A review on colistin nephrotoxicity.
TL;DR: This review attempts to give a view on colistin nephrotoxicity, its prevalence especially in high doses, the mechanism of injury, risk factors, and prevention of this kidney injury.
Journal ArticleDOI
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
Ilad Alavi Darazam,Shervin Shokouhi,Mohamad Amin Pourhoseingholi,Seyed Sina Naghibi Irvani,Majid Mokhtari,Minoosh Shabani,Mahdi Amirdosara,Parham Torabinavid,Parham Torabinavid,Maryam Golmohammadi,SayedPayam Hashemi,Arsalan Azimi,Arsalan Azimi,Mohammad Hossein Jafarazadeh Maivan,Omidvar Rezaei,Alireza Zali,Mohammadreza Hajiesmaeili,Hadiseh Shabanpour Dehbsneh,Akram Hoseyni Kusha,Maryam Taleb Shoushtari,Negar Khalili,Azam Soleymaninia,Latif Gachkar,Ali Khoshkar +23 more
TL;DR: In patients with laboratory-confirmed SARS-CoV-2 infection, as compared with the base therapeutic regiment, the benefit of a significant reduction in TTCI was observed in the IFNβ1a arm, and this finding needs further confirmation in larger studies.